Edgestream Partners, L.P. Novartis Ag Transaction History

Edgestream Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $1.23 Million - $1.43 Million	-15,253 Reduced 20.41%	59,479 $5.03 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $5.99 Million - $6.77 Million	74,732 New	74,732 $6.56 Million
Q4 2021 Feb 15, 2022	SELL	$79.7 - $88.13 $9.42 Million - $10.4 Million	-118,155 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $9.66 Million - $11.2 Million	118,155 New	118,155 $9.66 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.